Natera Company Profile (NASDAQ:NTRA)

About Natera

Natera logoNatera, Inc. is a diagnostics company. The Company's product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening (Horizon) to determine carrier status for various severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening (PGS) and Spectrum Pre-implantation Genetic Diagnosis (PGD) to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization (IVF) cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father(s).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NTRA
  • CUSIP:
Key Metrics:
  • Previous Close: $9.95
  • 50 Day Moving Average: $10.65
  • 200 Day Moving Average: $11.20
  • 52-Week Range: $6.52 - $13.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.50
  • P/E Growth: 0.00
  • Market Cap: $515.22M
  • Outstanding Shares: 51,781,000
  • Beta: 2.04
  • Net Margins: -34.23%
  • Return on Equity: -39.38%
  • Return on Assets: -27.49%
  • Current Ratio: 2.48%
  • Quick Ratio: 2.39%
Additional Links:
Companies Related to Natera:

Analyst Ratings

Consensus Ratings for Natera (NASDAQ:NTRA) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.00 (80.90% upside)

Analysts' Ratings History for Natera (NASDAQ:NTRA)
DateFirmActionRatingPrice TargetDetails
8/5/2016Morgan StanleySet Price TargetBuy$20.00View Rating Details
6/3/2016Cowen and CompanyReiterated RatingOutperform$17.00View Rating Details
5/23/2016Benchmark Co.Boost Price TargetBuy$15.00 -> $16.00View Rating Details
3/11/2016Piper Jaffray Cos.Reiterated RatingOverweight$24.00 -> $22.00View Rating Details
3/9/2016Robert W. BairdLower Price TargetOutperform$18.00 -> $15.00View Rating Details
9/28/2015WedbushUpgradeNeutral -> Outperform$20.00View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Natera (NASDAQ:NTRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.48)($0.46)$50.64 million$52.00 millionViewListenView Earnings Details
5/10/2016Q116($0.46)($0.17)$48.17 million$61.90 millionViewListenView Earnings Details
3/8/2016Q415($0.64)($0.47)$45.26 million$52.90 millionViewListenView Earnings Details
11/12/2015Q315($0.46)($0.39)$43.08 million$44.90 millionViewListenView Earnings Details
8/12/2015($0.44)($0.40)$42.69 million$45.09 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Natera (NASDAQ:NTRA)
Current Year EPS Consensus Estimate: $-1.69 EPS
Next Year EPS Consensus Estimate: $-1.17 EPS


Dividend History for Natera (NASDAQ:NTRA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Natera (NASDAQ:NTRA)
Insider Ownership Percentage: 18.91%
Institutional Ownership Percentage: 63.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2016Herm RosenmanCFOSell1,773$11.53$20,442.69View SEC Filing  
10/5/2016Jonathan SheenaInsiderSell1,600$12.00$19,200.00View SEC Filing  
9/6/2016Herm RosenmanCFOSell1,822$10.21$18,602.62View SEC Filing  
8/2/2016Herm RosenmanCFOSell1,833$12.98$23,792.34View SEC Filing  
7/6/2016Herm RosenmanCFOSell1,824$12.10$22,070.40View SEC Filing  
7/1/2016Matthew RabinowitzCEOSell104,892$12.14$1,273,388.88View SEC Filing  
6/19/2016Jonathan SheenaCTOSell188,442$11.94$2,249,997.48View SEC Filing  
6/19/2016Matthew RabinowitzCEOSell732,831$11.94$8,750,002.14View SEC Filing  
6/19/2016Roelof BothaDirectorBuy837,521$11.94$10,000,000.74View SEC Filing  
6/2/2016Herm RosenmanCFOSell1,806$12.04$21,744.24View SEC Filing  
2/1/2016Jonathan SheenaCTOSell10,000$8.03$80,300.00View SEC Filing  
1/5/2016Matthew RabinowitzCEOSell54,683$10.37$567,062.71View SEC Filing  
1/4/2016Jonathan SheenaCTOSell25,000$10.06$251,500.00View SEC Filing  
12/31/2015Matthew RabinowitzCEOSell111,513$10.83$1,207,685.79View SEC Filing  
12/29/2015Jonathan SheenaCTOSell50,000$10.44$522,000.00View SEC Filing  
12/29/2015Matthew RabinowitzCEOSell83,804$10.62$889,998.48View SEC Filing  
7/8/2015James HealyDirectorBuy350,000$18.00$6,300,000.00View SEC Filing  
7/2/2015James HealyDirectorBuy400,000$22.81$9,124,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Natera (NASDAQ:NTRA)
News IconStock Analyst Price Target Update on Natera Inc (NASDAQ:NTRA) - Recall News (NASDAQ:NTRA) - October 22 at 10:33 AM logoTrusource Labs leases up North Austin office building; More companies headed that way (NASDAQ:NTRA) - October 19 at 6:50 PM logoETF’s with exposure to Natera, Inc. : October 19, 2016 (NASDAQ:NTRA) - October 19 at 6:50 PM
News IconLooking Ahead for Natera Inc (NASDAQ:NTRA); Are These Shares Ready to Go Higher? - CSZ News (NASDAQ:NTRA) - October 18 at 6:23 PM logoNatera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : October 18, 2016 (NASDAQ:NTRA) - October 18 at 11:48 AM
News IconLatest Analyst Ratings For Natera, Inc. (NASDAQ:NTRA) - The De Soto Edge (NASDAQ:NTRA) - October 16 at 6:17 PM logoNatera Inc (NASDAQ:NTRA) Files An 8-K (NASDAQ:NTRA) - October 16 at 10:52 AM
News IconNatera, Inc. (NASDAQ:NTRA) - Broker Update - NewsDen - NewsDen (NASDAQ:NTRA) - October 15 at 11:13 AM logoNatera Inc (NASDAQ:NTRA) Files An 8-K - Market Exclusive (NASDAQ:NTRA) - October 14 at 6:17 PM
News IconDo Analysts See Any Upside to Natera Inc (NASDAQ:NTRA)? - Recall News (NASDAQ:NTRA) - October 13 at 6:36 PM logoNATERA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:NTRA) - October 13 at 10:06 AM logoNatera Announces Two Poster Presentations on Triploidy and Duchenne Muscular Dystrophy to be Featured at the 2016 American Society for Reproductive Medicine (ASRM) Conference (NASDAQ:NTRA) - October 13 at 10:06 AM
News IconNatera, Inc. (NASDAQ:NTRA) Updated Broker Price Targets - The De Soto Edge (NASDAQ:NTRA) - October 9 at 10:45 AM
News IconStock Perspective: Natera Inc (NASDAQ:NTRA) Company Earnings Watch - CSZ News (NASDAQ:NTRA) - October 5 at 11:44 AM logoETF’s with exposure to Natera, Inc. : October 4, 2016 (NASDAQ:NTRA) - October 4 at 11:15 AM logoNatera, Inc. – Value Analysis (NASDAQ:NTRA) : October 4, 2016 (NASDAQ:NTRA) - October 4 at 11:15 AM logoNatera, Inc. breached its 50 day moving average in a Bullish Manner : NTRA-US : October 3, 2016 (NASDAQ:NTRA) - October 3 at 11:03 AM
News IconBroker Outlook For Natera, Inc. (NASDAQ:NTRA) - The De Soto Edge - The De Soto Edge (NASDAQ:NTRA) - September 29 at 11:37 AM
News IconWhat is the Street Saying About Natera Inc (NASDAQ:NTRA)? - Frisco Fastball (NASDAQ:NTRA) - September 26 at 11:13 AM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Natera Inc (NASDAQ:NTRA) Stock - Frisco Fastball (NASDAQ:NTRA) - September 23 at 11:11 AM
News Icon1806 Shares of Natera Inc (NTRA) Stock are sold by Herm Rosenman - DailyQuint (NASDAQ:NTRA) - September 19 at 10:59 AM
News IconStock Down Over the Last Quarter: Natera, Inc. (NASDAQ:NTRA) - Post News (NASDAQ:NTRA) - September 18 at 6:02 PM logoETF’s with exposure to Natera, Inc. : September 16, 2016 (NASDAQ:NTRA) - September 16 at 6:17 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Natera Inc (NASDAQ:NTRA) - Frisco Fastball (NASDAQ:NTRA) - September 15 at 6:32 PM
News IconEarnings Analysis & Update for Natera Inc (NASDAQ:NTRA)? - Frisco Fastball (NASDAQ:NTRA) - September 15 at 6:32 PM
News IconSell-side Consensus Sees Natera Inc (NASDAQ:NTRA) Going Where Near-Term? - Frisco Fastball (NASDAQ:NTRA) - September 13 at 11:23 AM
News IconNatera Inc. (NTRA) Shares Down 4.6% - NewsDen (NASDAQ:NTRA) - September 10 at 10:45 AM
News IconPlacing Natera Inc (NASDAQ:NTRA) Shares Under the Microscope - Post News (NASDAQ:NTRA) - September 7 at 6:38 PM logoNatera to Present at the Baird 2016 Global Healthcare Conference (NASDAQ:NTRA) - September 2 at 6:26 PM
News IconShares Slipping Lower Over the Past Month: Natera, Inc. (NASDAQ:NTRA) - Post News (NASDAQ:NTRA) - September 1 at 6:27 PM logoETF’s with exposure to Natera, Inc. : August 30, 2016 (NASDAQ:NTRA) - August 30 at 6:28 PM
News IconStock Heading Down Over the Last Month Natera, Inc. (NASDAQ:NTRA) - Post News (NASDAQ:NTRA) - August 25 at 6:30 PM
News IconIs it Time to Buy Natera Inc (NASDAQ:NTRA)? Crowd & Analysts Weigh in - Post News (NASDAQ:NTRA) - August 25 at 6:30 PM logoNATERA, INC. Financials (NASDAQ:NTRA) - August 20 at 6:12 PM
News IconStock Sliding Lower in Trade: Natera, Inc. (NASDAQ:NTRA) - Post News (NASDAQ:NTRA) - August 19 at 6:28 PM
News IconShares Moving Lower Over the Past Month Natera, Inc. (NASDAQ:NTRA) - Post News (NASDAQ:NTRA) - August 18 at 6:42 PM
News IconNatera, Inc.'s (NTRA): Notable Runner - Hot Stocks Point (NASDAQ:NTRA) - August 18 at 6:42 PM logoEdited Transcript of NTRA earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:NTRA) - August 15 at 6:50 PM logoNATERA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:NTRA) - August 11 at 6:59 PM logoNatera, Inc. :NTRA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:NTRA) - August 10 at 6:58 PM logoETF’s with exposure to Natera, Inc. : August 9, 2016 (NASDAQ:NTRA) - August 9 at 6:47 PM logoHealthcare Volatile Stocks: Natera, Inc. (NASDAQ:NTRA), OvaScience, Inc. (NASDAQ:OVAS), Ritter Pharmaceuticals ... - KC Register (NASDAQ:NTRA) - August 8 at 11:14 AM logoNatera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : August 8, 2016 (NASDAQ:NTRA) - August 8 at 11:14 AM logoNatera reports 2Q loss (NASDAQ:NTRA) - August 5 at 9:36 AM logoNatera Reports Second Quarter 2016 Financial Results (NASDAQ:NTRA) - August 4 at 6:55 PM logoQ2 2016 Natera Inc Earnings Release - After Market Close (NASDAQ:NTRA) - August 4 at 9:44 AM logoNatera and UCSF Initiate Collaboration to Study DNA Markers of Kidney Transplant Rejection (NASDAQ:NTRA) - August 1 at 8:31 AM logo8:04 am Natera and UCSF initiate collaboration to study DNA markers of kidney transplant rejection (NASDAQ:NTRA) - August 1 at 8:04 AM
News IconNew ACMG guidelines recommend NIPT as optimal initial screening test for all pregnant women (NASDAQ:NTRA) - July 30 at 5:55 PM logoNatera : Announces Second Quarter Earnings Conference Call (NASDAQ:NTRA) - July 29 at 6:41 PM


Natera (NASDAQ:NTRA) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff